Mutations in the KRAS gene are the primary driver of pancreatic cancer. A new class of drugs known as KRAS…
Read More »inhibitors
A genetic disorder leads to an increase in bioactive lipids in the brain, resulting in an imbalance between excitation and…
Read More »
Many people who’ve had breast cancer take medications – tamoxifen or aromatase inhibitors – to help prevent the cancer from…
Read More » Scientists at Duke-NUS Medical School have uncovered why some pancreatic and colorectal cancers[1] fail to respond to Wnt inhibitors, a…
Read More »